MRK
Merck & Company Inc
145.30$
-2.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +58.0% | -16.5% | -37.9% | +69.4% | +23.1% | -23.7% | +37.6% | +35.3% | -31.9% | +65.1% | -23.3% | |
| – | -4.7% | -14.7% | -14.8% | -2.5% | -19.2% | -0.7% | -11.3% | +21.6% | -0.9% | +16.2% | +29.8% | |
| – | +7.6% | +0.3% | +4.0% | +11.5% | +19.8% | +13.9% | +0.8% | +12.9% | +19.2% | +18.0% | +7.8% | |
| – | – | +93.8% | -139.9% | – | +86.7% | -29.0% | +87.0% | -26.7% | – | – | – | |
| – | -114.7% | – | – | – | – | – | – | – | – | – | – | |
| – | -44.6% | +25.8% | +17.0% | +38.5% | +32.8% | +34.9% | -5.0% | -1.3% | -12.0% | -12.7% | +21.9% | |
| – | +1,172.2% | -32.5% | – | +61.0% | -160.9% | +259.2% | +75.3% | -70.0% | +183.9% | -45.1% | +77.7% | |
| – | -2.5% | +0.1% | +0.8% | +0.1% | +10.1% | +9.1% | +6.4% | +6.1% | +6.2% | +5.3% | +4.3% | |
| – | -45.7% | -18.0% | +16.9% | +126.5% | -47.4% | -73.2% | -34.4% | – | -450.5% | -3.0% | +289.3% | |
| – | – | -137.4% | -13.6% | – | +49.1% | +301.5% | -67.5% | -238.0% | – | -44.8% | +392.7% | |
| – | -64.4% | +67.9% | +10.6% | +31.5% | -32.7% | -68.0% | – | -451.7% | -47.3% | +46.2% | -72.7% | |
| – | – | -285.5% | – | – | +5.1% | -189.9% | – | +32,800.0% | -227.3% | – | -78.6% | |
| – | +72.0% | -22.2% | -47.9% | +82.1% | +20.0% | -44.1% | +73.5% | +52.2% | -37.8% | +97.9% | -31.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.